Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110452150A reveals a novel synthesis route. Offers high optical purity and mild conditions for reliable chiral pharmaceutical intermediate supply chains.
Patent CN116813544B reveals metal-free heating synthesis for quinoline intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective API intermediate manufacturing solutions.
Novel metal-free route for trifluoromethyl pyrazoles. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN115260080B details efficient indole-3-carboxamide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals metal-free heating-promoted synthesis. Delivers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN119823040A details a palladium-catalyzed synthesis method offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN113801050A details a novel copper-catalyzed interrupted Kinugasa reaction for synthesizing highly functionalized beta-lactam intermediates with excellent enantioselectivity and mild conditions.
Novel FeCl3 catalyzed route offers high yield and scalability for quinazolinone API intermediates, reducing costs and improving supply chain reliability.
Patent CN116396203B reveals copper-catalyzed oxidation for high-purity indole intermediates. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Discover the novel TBAI-catalyzed oxidative cyclization method for high-purity 1,2,4-triazole intermediates. A cost-effective, metal-free route for pharmaceutical manufacturing.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN112898192B details a novel Pd-catalyzed carbonylation cyclization. Offers high yield and substrate tolerance for pharmaceutical intermediates.
Novel CuCl catalyzed route for high-purity triazolyl arylamines. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chiral phosphoric acid catalysis enables high yield synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed one-pot method for high-purity fused heterocycles. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles. High yield, mild conditions, scalable for pharmaceutical intermediates.
Patent CN113087714B discloses a novel Rh(II)-catalyzed N-H insertion method for axial chiral aryl indole carbazoles, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN118126005B reveals metal-free synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.